Skip to main content
SpringerLink
Log in

Dysregulation of G Protein-Coupled Receptor Signaling in Cancer

  • Chapter
  • First Online:
Signal Transduction: Pathways, Mechanisms and Diseases

  • 1909 Accesses

Abstract

G protein-coupled receptors (GPCRs) are the largest family of signaling receptors in the mammalian genome and elicit responses to a plethora of extracellular stimuli. Moreover, nearly half the drugs currently in use for the treatment of a variety of human diseases target GPCRs either directly or indirectly. A role for dysregulated GPCR signaling in tumor progression is supported by a substantial amount of literature. GPCRs are overexpressed in various types of malignant cancers. In certain endocrine tissues, mutations in specific GPCRs and G proteins result in aberrant signaling, which contributes to cancer progression. In other tissue types, GPCR overexpression coupled with the abundance of activating ligands generated in the tumor microenvironment drives tumor progression. Desensitization and receptor trafficking control the magnitude, duration and spatial aspects of GPCR signaling. Most GPCRs are internalized through clathrin-coated pits and recycled back to the plasma membrane or sorted to lysosomes and degraded. Recent studies suggest that defects in GPCR trafficking contribute to receptor overexpression and aberrant signaling. Recent work also indicates that dysregulation of the trafficking machinery, due in part to aberrant ubiquitination, alters GPCR trafficking and signaling, and thereby contributes to tumor progression.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Arora P, Cuevas B, Russo A, Johnson GL, Trejo J (2008) Persistent transactivation of EGFR and ErbB2/HER2 by protease-activated receptor-1 promotes breast carcinoma cell invasion. Oncogene 27:4434–4445

    Article  CAS  PubMed  Google Scholar 

  • Arora P, Ricks TK, Trejo J (2007) Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer J. Cell Sci 120:921–928

    Article  CAS  Google Scholar 

  • Boire A, Covic L, Agarwal A, Jacques S, Sherifi S, Kuliopulos A (2005) PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell 120:303–313

    Article  CAS  PubMed  Google Scholar 

  • Booden MA, Ekert L, Der CJ, Trejo J (2004) Persistent signaling by dysregulated thrombin receptor trafficking promotes breast carcinoma cell invasion. Mol Cell Biol 24:1990–1999

    Article  CAS  PubMed  Google Scholar 

  • Bradley SV, Holland EC, Liu GY, Thomas D, Hyun TS, Ross TS (2007) Huntington interacting protein-1 is a novel brain tumor marker that associates with epidermal growth factor receptor. Cancer Res 8:3609–3615

    Article  Google Scholar 

  • Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN (2006) Role of β-arrestin 1in the metastatic progression of colorectal cancer. Proc Natl Acad Sci U S A 103:1492–1497

    Article  CAS  PubMed  Google Scholar 

  • Chan AM-L, Fleming TP, McGovern ES, Chedid M, Miki T, Aaronson SA (1993) Expression cDNA Cloning of a Transforming Gene Encoding the Wild-type Gα12 Gene Product. Mol Cell Biol 13:762–768

    CAS  PubMed  Google Scholar 

  • Cullen PJ (2008) Endosomal sorting and signalling: an emerging role for sorting nexins. Nat Rev Mol Cell Biol 7:574–582

    Article  Google Scholar 

  • Dorsam RT, Gutkind JS (2007) G-protein-coupled receptors and cancer. Nat Rev Cancer 7:79–94

    Article  CAS  PubMed  Google Scholar 

  • Edeling MA, Smith C, Owen D (2006) Life of a clathrin coat: insights from clathrin and AP structures. Nat Mol Cell Biol 7:32–44

    Article  CAS  Google Scholar 

  • Engqvist-Goldstein AE, Zhang CX, Carreno S, Barroso C, Heuser JE, Drubin DG (2004) RNAi-mediated Hip1R silencing results in stable association between the endocytic machinery and the actin assembly machinery. Mol Biol Cell 4:1666–1679

    Article  Google Scholar 

  • Farfel Z, Bourne HR, Iiri T (1999) The expanding spectrum of G protein diseases. N Engl J Med 340:1012–1020

    Article  CAS  PubMed  Google Scholar 

  • Freedman DA, Wu L, Levine AJ (1999) Function of the MDM2 oncoprotein. Cell Mol Life Sci 55:96–107

    Article  CAS  PubMed  Google Scholar 

  • Ge L, Shenoy SK, Lefkowitz RJ, DeFea K (2004) Constitutive protease-activated-receptor-2 mediated migration of MDA-MB-231 breast cancer cells requires both β-arrestin-1 and 2. J Biol Chem 279:55419–55424

    Article  CAS  PubMed  Google Scholar 

  • Goldsmith ZG, Dhanasekaran DN (2007) G protein regulation of MAPK networks. Oncogene 26:3122–3142

    Article  CAS  PubMed  Google Scholar 

  • Goodman OB Jr, Krupnick JG, Santini F, Gurevich VV, Penn RB, Gagnon AW, Keen JH, Benovic JL (1996) Beta-arrestin acts as a clathrin adaptor in endocytosis of the Beta2-adrenergic receptor. Nature 383:447–450

    Article  CAS  PubMed  Google Scholar 

  • Gullapalli A, Wolfe BL, Griffin CT, Magnuson T, Trejo J (2006) An essential role for SNX1 in lysosomal sorting of protease-activated receptor-1: evidence for retromer, Hrs and Tsg101 independent functions of sorting nexins. Mol Biol Cell 17:1228–1238

    Article  CAS  PubMed  Google Scholar 

  • Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70

    Article  CAS  PubMed  Google Scholar 

  • Jacob C, Cottrell GS, Gehringer D, Schmidlin F, Grady EF, Bunnett NW (2005) c-Cbl mediates ubiquitination, degradation, and down-regulation of human protease-activated receptor 2. J Biol Chem 280:16076–16087

    Article  CAS  PubMed  Google Scholar 

  • Jaffe AB, Hall A (2002) Rho GTPases in transformation and metastasis. Adv. Cancer Res. 84:57–80

    Article  CAS  PubMed  Google Scholar 

  • Kelly P, Casey PJ, Meigs TE (2007) Biologic functions of the G12 subfamily of heterotrimeric G proteins: growth, migration and metastasis. Biochemistry 46:6677–6687

    Article  CAS  PubMed  Google Scholar 

  • Kelly P, Moeller BJ, Juneja J, Booden MA, Der CJ, Daaka Y, Dewhirst MW, Fields TA, Casey PJ (2006) The G12 family of heterotrimeric G proteins promotes breast cancer invasion and metastasis. Proc Natl Acad Sci 103:8173–8178

    Article  CAS  PubMed  Google Scholar 

  • Kenakin T (2007) Collateral efficacy in drug discovery: taking advantage of the good (allosteric) nature of 7TM receptors. Trends Pharmacol Sci 26:407–415

    Article  Google Scholar 

  • Kerscher O, Felberbraum R, Hochstrasser M (2006) Modifications of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 22:159–180

    Article  CAS  PubMed  Google Scholar 

  • Krupnick JG, Benovic JL (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol 38:289–319

    Article  CAS  PubMed  Google Scholar 

  • Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE (1996) Kiss-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 20:1549

    Google Scholar 

  • Lefkowitz RJ, Shenoy SK (2005) Transduction of receptor signals by β-arrestins. Science 308:512–517

    Article  CAS  PubMed  Google Scholar 

  • Li YM, Pan Y, Wei Y, Cheng X, Zhou BP, Tan M, Zhou X, Xia W, Hortobagyi GN, Yu D, Hung M-C (2004) Upregulation of CXCR4 is essential for HER2-mediated tumor metastasis. Cancer Cell 6:459–469

    Article  CAS  PubMed  Google Scholar 

  • Marchese A, Benovic JL (2001) Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J Biol Chem 276:45509–45512

    Article  CAS  PubMed  Google Scholar 

  • Marchese A, Paing MM, Temple BRS, Trejo J (2008) G Protein-coupled receptor sorting to endosomes and lysosomes. Annu Rev Pharmcol Toxicol 48:601–629

    Article  CAS  Google Scholar 

  • Marchese A, Raiborg C, Santini F, Keen JT, Stenmark H, Benovic JL (2003) The E3 ubiquitin ligase AIP4 mediates ubiquitination and sorting of the G protein-coupled receptor CXCR4. Dev Cell 5:709–722

    Article  CAS  PubMed  Google Scholar 

  • Maussang D, Verzijl D, van Walsum M, Leurs R, Holl J, Pleskoff O, Michel D, van Dongen GA, Smit MJ (2006) Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. Proc Natl Acad Sci U S A 35:13068–13073

    Article  Google Scholar 

  • Mills GB, Moolenaar WH (2003) The emerging role of lysophosphatidic acid in cancer. Nat Rev Cancer 3:582–591

    Article  CAS  PubMed  Google Scholar 

  • Moberg KH, Schelble S, Burdick SH, Hariharan IK (2005) Mutations in erupted, the drosophila ortholog of mammalian tumor susceptibility gene 101, elicit non-cell autonomous overgrowth. Dev Cell 5:699–710

    Article  Google Scholar 

  • Moore CAC, Milano SK, Benovic JL (2007) Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol 69:19.11–19.32

    Article  Google Scholar 

  • Moseson Y, Mills GB, Yarden Y (2008) Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer 8:835–850

    Article  Google Scholar 

  • Nahta R, Esteva FJ (2007) Trastuzumab: triumphs and tribulations. Oncogene 26:3637–3643

    Article  CAS  PubMed  Google Scholar 

  • Oh KB, Stanton MJ, West WW, Todd GL, Wagner KU (2007) Tsg101 is upregulated in a subset of invasive human breast cancers and its targeted overexpression in transgenic mice reveals weak oncogenic properties for mammary cancer initiation. Oncogene 26:5950–5959

    Article  CAS  PubMed  Google Scholar 

  • Oldham WM, Hamm HE (2007) Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev. Mol, Cell Biol

    Google Scholar 

  • Parnot C, Miserey-Lenkei S, Bardin S, Corvol P, Clauser E (2002) Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrino Metabol 13:336–343

    Article  CAS  Google Scholar 

  • Paulsen SJ, Rosenkilde MM, Eugen-Olsen J, Kledeal TN (2005) Epstein-Barr virus encoded BILF1 is a constitutively active G protein-coupled receptor. J. Virol. 79:536–546

    Article  CAS  PubMed  Google Scholar 

  • Piper RC, Katzmann DJ (2007) Biogenesis and function of multivesicular bodies. Annu Rev Cell Dev Biol 23:519–547

    Article  CAS  PubMed  Google Scholar 

  • Radhika V, Dhanasekaran N (2001) Transforming G proteins. Oncogene 20:1607–1614

    Article  CAS  PubMed  Google Scholar 

  • Rao DS, Bradley SV, Kumar PD, Hyun TS, Saint-Dic D, Oravecz-Wilson K, Kleer CG, Ross TS (2003) Altered receptor trafficking in Huntingtin Interacting Protein-1 transformed cells. Cancer Cell 5:471–482

    Article  Google Scholar 

  • Schmid SL (1997) Clathrin-coated vesicle formation and protein sorting: an integrated process. Annu Rev Biochem 66(33):511–548

    Article  CAS  PubMed  Google Scholar 

  • Slagsvold T, Marchese A, Brech A, Stenmark H (2006) CISK attenuates degradation of the chemokine receptor CXCR4 via the ubiquitin ligase AIP4. EMBO J 25:3738–3746

    Article  CAS  PubMed  Google Scholar 

  • Slamon DJ, Leyland-Jones D, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpress HER2. N Engl J Med 344:783–792

    Article  CAS  PubMed  Google Scholar 

  • Sodhi A, Montaner S, Gutkind JS (2004) Viral hijacking of G-protein-coupled-receptor signalling networks. Nat Rev Mol Cell Biol 5:998–1012

    Article  CAS  PubMed  Google Scholar 

  • Thomas P, Paing Y, Filardo EJ, Dong J (2005) Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 146:624–632

    Article  CAS  PubMed  Google Scholar 

  • Tobin AB, Butcher AJ, Kong KC (2008) Location, location, location...site specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends Pharmacol Sci 8:413–420

    Article  Google Scholar 

  • Versteeg HH, Schaffner F, Kerver M, Ellies LG, Andrade-Gordon P, Mueller BM, Ruf W (2008) Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. Cancer Res 17:7219–7227

    Article  Google Scholar 

  • Wang Y, Zhou Y, Szabo K, Haft CR, Trejo J (2002) Down-regulation of protease-activated ­receptor-1 is regulated by sorting nexin 1. Mol Biol Cell 13:1965–1976

    Article  CAS  PubMed  Google Scholar 

  • Whitehead I, Zohn IE, Der CJ (2001) Rho GTPase-dependent transformation by G protein-­coupled receptors. Oncogene 20:1547–1555

    Article  CAS  PubMed  Google Scholar 

  • Wolfe BL, Marchese A, Trejo J (2007) Ubiquitination differentially regulates clathrin-dependent internalization of protease-activated receptor-1. J Cell Biol 177:905–916

    Article  CAS  PubMed  Google Scholar 

  • Xu N, Bradley L, Ambdukar I, Gutkind JS (1993) A mutant alpha subunit of G12 potentiates the eicosanoid pathway and is highly oncogenic in NIH 3 T3 cells. Proc Natl Acad Sci USA 90:6741–6745

    Article  CAS  PubMed  Google Scholar 

  • Yin Y-J, Salah Z, Grisaru-Granovsky S, Cohen I, Even-Ram S, Maoz M, Uziely B, Peretz T, ­Bar-Shavit R (2003a) Human Protease-Activated Receptor-1 Expression in Malignant Epithelia: A Role In Invasiveness. Aterioscler Thromb Vasc Biol 23:940–944

    Article  CAS  Google Scholar 

  • Yin Y-J, Salah Z, Grisaru-Granovsky S, Cohen I, Even-Ram S, Maoz M, Uziely B, Peretz T, ­Bar-Shavit R (2003b) Oncogenic transformation induces tumor angiogenesis: a role for PAR1 activation. FASEB J 17:163–174

    Article  CAS  PubMed  Google Scholar 

  • Young D, Waitches G, Birchmeier C, Fasano O, Wigler M (1986) Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 45(5):711–719

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of California, La Jolla, CA, USA

    JoAnn Trejo

Authors
  1. JoAnn Trejo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to JoAnn Trejo .

Editor information

Editors and Affiliations

  1. Eye Research Institute, Oakland University, DHE 423, Rochester, 48309, USA

    Ari Sitaramayya

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Trejo, J. (2010). Dysregulation of G Protein-Coupled Receptor Signaling in Cancer. In: Sitaramayya, A. (eds) Signal Transduction: Pathways, Mechanisms and Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02112-1_5

Download citation

Publish with us

Policies and ethics

Search

Navigation